Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Champions Oncology, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 45 | 38 | −7 |
| Shares | 7.20M | 6.66M | −545.6K (−7.6%) |
| Value | $81.4M | $68.5M | −$12.9M (−15.9%) |
New holders (5)
Institutions that held Champions Oncology, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 88,310 | $908.0K | 0.00% |
| ACT Capital Management, LLC | 50,000 | $514.0K | 0.26% |
| Ergoteles LLC | 30,900 | $318.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 28,382 | $292.0K | 0.01% |
| HRT Financial LP | 14,967 | $153.0K | 0.00% |
Sold out (12)
Institutions that held Champions Oncology, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| STRS Ohio | 31,500 | $355.0K |
| Charles Schwab Investment Management Inc | 15,613 | $177.0K |
| Cowen Prime Services LLC | 13,500 | $153.0K |
| Nuveen Asset Management, LLC | 12,642 | $143.0K |
| California State Teachers Retirement System | 9,731 | $110.0K |
| Deutsche Bank AG | 4,129 | $47.0K |
| American International Group, Inc. | 3,945 | $45.0K |
| Legal & General Group Plc | 690 | $8.00K |
| Total Clarity Wealth Management, Inc. | 713 | $8.00K |
| Ameritas Investment Partners, Inc. | 637 | $7.00K |
| Citigroup Inc | 449 | $5.00K |
| O'Shaughnessy Asset Management, LLC | 25 | $0 |